Bryan Adrian Priego-Parra

Bryan Adrian Priego-Parra

Auto-generated profile, based on publicly available information

Bryan Adrian Priego-Parra

Instituto de Investigaciones Médico-Biológicas, Universidad Veracruzana, Veracruz, Mexico; Centro de Investigaciones Biomédicas, Universidad Veracruzana, Veracruz, Mexico

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2025 in Trends in Endocrinology & Metabolism
Verified
Journal Article
Closed access
BPBryan A. Priego-Parra
Bryan A. Priego-Parra
RGRocio Gallego-Duran
Rocio Gallego-Duran
BRBerenice Román
Berenice Román
JVJose Antonio Velarde-Ruiz Velasco
Jose Antonio Velarde-Ruiz Velasco
MRManuel Romero-Gómez
Manuel Romero-Gómez
Jordi Gracia-SanchoJordi Gracia-Sancho
Jordi Gracia-Sancho

19 January 2024 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
BPBryan Adrian Priego‐Parra
Bryan Adrian Priego‐Parra
ATArturo Triana‐Romero
Arturo Triana‐Romero
FLFrancisco Antonio Lajud‐Barquín
Francisco Antonio Lajud‐Barquín
MHMaría de Fátima Higuera‐DelaTijera
María de Fátima Higuera‐DelaTijera
SMSophia Eugenia Martínez‐Vázquez
Sophia Eugenia Martínez‐Vázquez
JRJose Maria Remes-Troche
Jose Maria Remes-Troche

12 November 2024 in Journal of Clinical Gastroenterology
Verified
Journal Article
Closed access
HOHector Ricardo Ordaz-Alvarez
Hector Ricardo Ordaz-Alvarez
BPBryan Adrian Priego-Parra
Bryan Adrian Priego-Parra
SRSara Alejandra Reyes-Diaz
Sara Alejandra Reyes-Diaz
KGKarla Rocio Garcia-Zermeño
Karla Rocio Garcia-Zermeño
MFMaria Rd del Rocio Francisco
Maria Rd del Rocio Francisco
JRJose Maria Remes-Troche
Jose Maria Remes-Troche
Goal: To investigate the prevalence of eating disorder (ED) symptoms among Mexican adults with irritable bowel syndrome (IBS). Background: The relationship between IBS and EDs is complex, yet understudied, particularly in Latin America. Methods: In this cross-sectional study, 369 Mexican adults (18 to 69 y), comprising 133 IBS patients and 236 healthy controls (HCs), were evaluated using the Rome IV criteria, The Spanish version of the Eating Disorder Examination Questionnaire (S-EDE-Q), the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) and the Hospital Anxiety and Depression Scale (HADS). Statistical analysis included the Student t test or the Wilcoxon Rank-sum test for group comparisons, the Kruskal-Wallis test for multiple comparisons, and logistic regression, with a significance threshold set at a P-value of <0.05. Results: IBS individuals were at an increased risk for clinically significant S-EDE-Q when compared with HCs (12.8% vs. 3.8%, odds ratio OR 3.6, 95% CI: 1.5-8.5; P=0.001), especially among younger individuals. IBS individuals displayed a higher risk for dietary restraint and heightened concerns about eating, body shape, and weight. In addition, binge-eating episodes occurred more frequently within the IBS group. Notably, there were no significant differences in body mass index between individuals with clinically significant S-EDE-Q and those with normal scores. IBS individuals with severe symptoms had higher S-EDE-Q scores; furthermore, those with IBS and clinically significant S-EDE-Q exhibited higher levels of anxiety and depression. Conclusions: Our study reveals a significantly higher risk for ED in IBS individuals compared with HCs. This highlights the crucial importance of conducting ED screenings before dietary interventions, particularly among younger individuals and those displaying elevated levels of anxiety and depression.

24 March 2025 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
BPBryan Adrian Priego‐Parra
Bryan Adrian Priego‐Parra
SRSara Alejandra Reyes‐Diaz
Sara Alejandra Reyes‐Diaz
HAHector Ricardo Ordaz Alvarez
Hector Ricardo Ordaz Alvarez
GMGénesis‐Patricia Martínez‐Pérez
Génesis‐Patricia Martínez‐Pérez
MAMercedes Amieva‐Balmori
Mercedes Amieva‐Balmori
JRJosé María Remes‐Troche
José María Remes‐Troche

1 March 2022
Verified
Journal Article
Open access
GSGiovanni Alejandro Salgado-Álvarez
Giovanni Alejandro Salgado-Álvarez
PGPeter Grube-Pagola
Peter Grube-Pagola
GMGustavo Martinez Mier
Gustavo Martinez Mier
MMMaría Del Socorro Muñoz-Silva
María Del Socorro Muñoz-Silva
BPBryan Adrián Priego-Parra
Bryan Adrián Priego-Parra
JTJavier Alejandro Teco-Cortes
Javier Alejandro Teco-Cortes
Los mielolipomas suprarrenales (ML) son neoplasias benignas poco frecuentes constituidas por tejido adiposo y mieloide. Clínicamente asintomáticas, suelen ser diagnosticados incidentalmente. En México existen solo 32 casos publicados de ML, presentándose en pacientes de entre 37 a 65 años, siendo la relación hombre-mujer 1:1.1, el síntoma más comúnmente reportado es dolor abdominal inespecífico, y la cirugía abierta es el principal abordaje quirúrgico empleado en nuestro país (89%). presentamos una recopilación de la literatura actual sobre ML en México, además de dos casos clínicos de pacientes con ML: un hombre de 67 años con enfermedad diverticular y una mujer de 40 años con dolor en hipocondrio; en ambos se realizó resección tumoral, midiendo 9.5 cm y 13.3 cm, respectivamente. presentamos dos casos nuevos en nuestro país que corresponden a incidentalomas. En ambos casos la cirugía se realizó para confirmar el diagnóstico, así como para prevenir posibles complicaciones.

6 October 2026 in Archives of Medical Research
Verified
Journal Article
Closed access
JRJosé María Remes-Troche
José María Remes-Troche
LJLizet Jarquin-Yañez
Lizet Jarquin-Yañez
BPBryan Adrian Priego-Parra
Bryan Adrian Priego-Parra
JHJaque Review. Environmental Carcinogens and Cancer in Calderron Hernandez
Jaque Review. Environmental Carcinogens and Cancer in Calderron Hernandez
LRLuis Enrique Reyes-Arreguin
Luis Enrique Reyes-Arreguin
YLYelda A. Leal
Yelda A. Leal